Detalhe da pesquisa
1.
REMARK guidelines for tumour biomarker study reporting: a remarkable history.
Br J Cancer
; 128(3): 443-445, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476656
2.
Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network.
Cancer
; 128(21): 3843-3849, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089859
3.
Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products.
BMC Cancer
; 22(1): 512, 2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525914
4.
Sample size methods for evaluation of predictive biomarkers.
Stat Med
; 41(16): 3199-3210, 2022 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491401
5.
TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository.
J Transl Med
; 19(1): 269, 2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158060
6.
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
Mod Pathol
; 32(1): 59-69, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143750
7.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology
; 75(2): 225-235, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017314
8.
Criteria for the use of omics-based predictors in clinical trials.
Nature
; 502(7471): 317-20, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24132288
9.
Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.
Clin Trials
; 16(6): 599-609, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581815
10.
Issues in developing multivariable molecular signatures for guiding clinical care decisions.
J Biopharm Stat
; 26(6): 1098-1110, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27561083
11.
Metrology Standards for Quantitative Imaging Biomarkers.
Radiology
; 277(3): 813-25, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267831
12.
An international study to increase concordance in Ki67 scoring.
Mod Pathol
; 28(6): 778-86, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698062
13.
Comparison of confidence interval methods for an intra-class correlation coefficient (ICC).
BMC Med Res Methodol
; 14: 121, 2014 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25417040
15.
Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors.
Epigenetics
; 19(1): 2309824, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369747
16.
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
Clin Cancer Res
; 30(7): 1273-1280, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433347
17.
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
JCO Precis Oncol
; 8: e2300454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38591867
18.
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
JCO Precis Oncol
; 8: e2300407, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603650
19.
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
JCO Precis Oncol
; 8: e2300406, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603651
20.
Discussion: The role, position, and function of the FDA-The past, present, and future.
Biostatistics
; 18(3): 417-421, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28633307